Current filters:

Start a new search
Add filters:

Use filters to refine the search results.

Results 1-10 of 35 (Search time: 0.003 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2006A Bayesian approach for population pharmacokinetic modelling of sirolimusDansirikul, C.; Morris, R.; Tett, S.; Duffull, S.
2003Tacrolimus measurement by microparticle enzyme immunoassay IITaylor, P.; Morris, R.
2005LC mass spectrometryMorris, R.; Taylor, P.
2006Comparison of the reintroduced MEIA (R) assay with HPLC-MS/MS for the determination of whole-blood sirolimus from transplant recipientsMorris, R.; Salm, P.; Taylor, P.; Wicks, F.; Theodossi, A.
2006Suspected DLIS interference in the dimension DGNA digoxin assay method and the clinical application of the revised digoxin target rangeMorris, R.; Jones, T.; Goldsworthy, S.; Wagner, T.; Ho, H.; Horowitz, J.
2005Relationships between sirolimus dosing, concentration and outcomes in renal transplant recipientsDansirikul, C.; Duffull, S.; Morris, R.; Tett, S.
2005Immunosuppressant drug monitoring: Is the laboratory meeting clinical expectations?Morris, R.
2006CEDIA (R) mycophenolic acid assay compared with HPLC-UV in specimens from transplant recipientsWestley, I.; Ray, J.; Morris, R.
2004Analytic aspects of cyclosporine monitoring, on behalf of the IFCC/IATDMCT joint working groupMorris, R.; Holt, D.; Armstrong, V.; Griesmacher, A.; Napoli, K.; Shaw, L.
2002International federation of clinical chemistry/international association of therapeutic drug monitoring and clinical toxicology working group on immunosuppressive drug monitoringHolt, D.; Armstrong, V.; Griesmacher, A.; Morris, R.; Napoli, K.; Shaw, L.